RhoA-directed siRNA exerted extraordinary tumor volume inhibitory effects (85% of tumor volume) in breast cancer, whereas when it was given with chitosan the tumor volume reduction was increased to 90% (to completely abolishing) for the higher dose. The gene discussed is RHOA; the disease is breast cancer.